Revised Genome Sequence of
There is growing interest in discovery of novel bioactive natural products from Burkholderia thailandensis. Here we report a significantly improved genome sequence and reannotation of Burkholderia thailandensis MSMB43, which will facilitate the discovery of new natural products through genome mining and studies of the metabolic versatility of this bacterium.
B
urkholderia thailandensis is a nonpathogenic Gram-negative bacillus that is emerging as a new source of diverse bioactive natural products (6, 7) . For example, more than 20 new compounds, including our reported thailandepsins A through F, have been isolated from B. thailandensis strain E264 in recent years (1, 2, 4, 5, 8-10, 13, 15-17) . To fully enable the discovery of novel natural products by genome mining, it is important to construct genome sequence assemblies of the highest quality, since they are the foundation for developing chemical separation and for engineering the biosynthetic pathways. The previously reported genome sequence of B. thailandensis MSMB43 contained numerous but often fragmented secondary metabolite biosynthetic genes or gene clusters, due to a poor-quality genome sequence. Here, we report the resequencing of the genome of B. thailandensis MSMB43 and we describe the sequence differences between the previously published assembly and our assembly.
The resequencing of B. thailandensis MSMB43 was performed with an Illumina genome analyzer (San Diego, CA), generating ϳ232.78 Mb of valid sequence data (about ϳ34.37-fold coverage), which was assembled into 176 contigs (N50, 102,479 bp) by using the SOAPdenovo program (http://soap.genomics.org.cn/). Paired-end information was then used to join the contigs into 61 scaffolds (N50, 959,023 bp). Compared to the previously reported draft genome sequence of B. thailandensis strain MSMB43 (GenBank accession number NZ_ABBM00000000), which contained 1,230 scaffolds (12), the quality of this new draft genome sequence is a significant improvement. In contrast to the draft genome of B. thailandensis MSMB43, we corrected 255 sequencing errors caused by continuous nucleotides (e.g., AAAAAA), 57 of which were in the coding region.
The new draft genome includes 7,209,234 bp and contains 6,201 coding sequences (CDSs), determined by combining the predictions from Glimmer and RAST, with a GϩC content of 67.19%. The former annotation of the B. thailandensis MSMB43 genome contained 7,426 CDSs, but 590 of them were very short (Ͻ50 amino acids). The new annotation corrected 1,204 CDSs, which were fragmented due to the incomplete contigs. There are single-copy genes predicted for 16S and 23S rRNA, duplicated genes predicted for 5S rRNA, and 55 genes predicted for tRNAs.
The antiSMASH program (11) was used to predict secondary metabolite biosynthetic genes of B. thailandensis MSMB43, revealing at least 13 putative gene clusters for biosynthesis, including lantibiotics, type I polyketide synthase (PKS)-produced polyketides (PKs), nonribosomal peptides (NRPs), terpenes, or hybrid PK/NRP molecules. Among those putative gene clusters, one is highly similar to the microcyclamide biosynthetic gene cluster of Microcystis aeroginosa NIES298 (18) , and another is similar to the FK228 (depsipeptide, an FDA-approved anticancer natural product) biosynthesis gene cluster of Chromobacterium violaceum no. 968 (3, 14) . This draft genome of B. thailandensis MSMB43 will enable us to explore secondary metabolites through genome mining and study the metabolic versatility of this bacterium in the future.
Nucleotide sequence accession numbers. The assembled shotgun genome sequences and annotations of B. thailandensis MSMB43 were deposited in DDBJ/EMBL/GenBank under accession number AJXB00000000. The version described in this paper is the first version, AJXB01000000.
